The Iowa Plaintiff alleges she needed constant medical monitoring, screening, testing, and treatments and that she will require more in the future. Food and Drug Administration (FDA) to publish a public health notice warning olmesartan medoxomil users (marketed as Benicar, Benicar HCT, Azor, Tribenzor, and generics) of the sprue-like enterophathy and related gastrointestinal (GI) problems allegedly caused by the hypertension medications. Yet it still took until July 2013 for the U.S. Researchers though, over the past few years, have discovered the use of Benicar and other olmesartan drugs have a high correlation with the development of several risky health conditions and harmful side effects. drug market in 2002, over 11 million patients have been prescribed the popular Daiichi drug every year. Since Benicar was first introduced into the U.S. During this time, the Plaintiff suffered several injuries including sprue-like enteropathy “with severe, chronic diarrhea resulting in substantial weight loss and malnutrition…” sustaining severe and permanent personal injuries in addition to constant pain and suffering.īenicar, Azor, and Tribenzor are hypertension medications made from the drug olmesartan. In November, an Iowa woman and her husband filed suit against the Japanese pharmaceutical company Daiichi Sankyo Inc., claiming that after being prescribed Azor in January 2011, she continued to take the hypertension medication as directed for some time. Less has been said about two other Daiichi Sankyo manufactured medications, Azor and Tribenzor, though lawsuits are on the rise. Much has been said and written about Benicar and its sprue-like enteropathy side effects, symptoms very much like that of celiac disease.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |